Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Farhad Malek has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Mehrdad Zahmatkesh

    Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran

    3 shared publications
  • Monir Nobahar

    Nursing Care Research Center, Semnan University of Medical Sciences, Semnan, Iran

    3 shared publications
  • Raheb Ghorbani

    Research Center for Social Determinants of Health and Research Center of Physiology, Department of Community Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

    3 shared publications
  • Raheb Ghorbani

    Social Determinants of Health Research Center, Semnan University of Medical Science, Semnan, Iran

    3 shared publications
  • Ali Gohari

    Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran

    2 shared publications
  • Hamid Reza Hemmati

    Clinical Research Development Unit, Kowsar Educational, Research and Therapeutic Hospital, Semnan University of Medical Sciences, Semnan, Iran

    2 shared publications

Latest Publications

  • Effect of clove mouthwash on the incidence of ventilator-associated pneumonia in intensive care unit patients: a comparative randomized triple-blind clinical trial

    by Mojgan Jahanshir, Monir Nobahar, Raheb Ghorbani, Farhad Malek

    Objectives Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections in intensive care units (ICUs), and the use of mouthwash is the most widely used method to prevent its incidence. The aim of this study was to investigate effect of clove mouthwash on the incidence of VAP in the ICU. Materials and methods This comparative, randomized, triple-blind, clinical trial was conducted on 168 eligible ICU patients at Kosar Hospital in Semnan, Iran, during 2021–2022, who were divided into intervention and control groups using random blocks. The intervention group received clove extract mouthwash at 6.66% concentration, and the control group received chlorhexidine 0.2% twice a day for 5 days (routine care). Data were collected using a demographic questionnaire, and disease severity was measured based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) score, oral health status was examined using the Beck Oral Assessment Scale (BOAS), and VAP diagnosis was made based on the Modified Clinical Pulmonary Infection Score (MCPIS). Results Before the intervention, there was no significant difference in disease severity (p = 0.412) and oral health status (p = 0.239) between the patients in the two groups. After the intervention, 20.2% of the patients in the intervention group and 41.7% of those in the control group acquired VAP. The risk of VAP was 2.06 times higher in the control group than in the intervention group (p = 0.005, 95% CI: 1.26–3.37, RR = 2.06), but the severity of VAP did not differ significantly between the patients in the two groups (p = 0.557). Conclusion The findings showed that clove mouthwash reduces the incidence of VAP significantly. Clinical relevance Clove mouthwash can be used as a simple and low-cost method to prevent VAP in ICU patients.


  • T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients

    by Tannaz Abbasi-Dokht, Arefe Vafaeinezhad, Negin Khalesi, Farhad Malek, Dariush Haghmorad, Rasoul Baharlou

    Introduction: The prevalence of coronavirus disease 2019 (COVID-19) has rapidly increased worldwide. More investigation is needed to progress toward understanding the exact role of immune responses in the pathology of the disease, leading to improved anticipation and treatment options. Methods: In the present study, we examined the relative expression of T-bet, GATA3, RORγt, and FoxP3 transcription factors as well as laboratory indicators in 79 hospitalized patients along with 20 healthy subjects as a control group. In order to make an exact comparison between various degrees of severity of disease, patients were divided into critical (n = 12) and severe (n = 67) groups. To evaluate the expression of genes of interest by performing real-time PCR, blood samples were obtained from each participant. Results: We found a significant increase in the expression of T-bet, GATA3, and RORγt and a reduction in the expression of FoxP3 in the critically ill patients compared to the severe and control groups. Also, we noticed that the GATA3 and RORγt expressions were elevated in the severe group in comparison with healthy subjects. Additionally, the GATA3 and RORγt expressions showed a positive correlation with elevation in CRP and hepatic enzyme concentration. Moreover, we observed that the GATA3 and RORγt expressions were the independent risk factors for the severity and outcome of COVID-19. Discussion: The present study showed that the overexpression of T-bet, GATA3, and RORγt, as well as a decrease in the FoxP3 expression was associated with the severity and fatal outcome of COVID-19.


  • Multistrain Probiotics Supplement Alleviates Asthma Symptoms via Increasing Treg Cells Population: A Randomized, Double-Blind, Placebo-Controlled Trial

    by Tannaz Abbasi-Dokht, Sina Sadrifar, Sarvenaz Forouzandeh, Farhad Malek, Maral Hemmati, Parviz Kokhaei, Amir Salek Farrokhi, Rasoul Baharlou

    Introduction: The favorable effects of probiotics have been demonstrated in allergic disorders. However, the underlying immunological mechanisms are poorly understood. In the present study, we investigated the improvement of clinical symptoms and immunological balance after receiving probiotics in patients with asthma. Methods: The present study was a randomized, double-blind, placebo-controlled trial in which 40 patients with asthma were enrolled. They were treated with probiotics or placebo: 1 capsule/day for 8 weeks. Pulmonary function test, percentage of CD4+ CD25+ FoxP3+ Tregs, and gene expression of T-bet, GATA-3, RORγt, and Foxp3 in PBMCs were assessed at baseline and after treatment. Results: Our results showed a significant increase in the expression of FoxP3 and CD4+ CD25+ FoxP3+ Tregs population, while RORγt and GATA3 expression were reduced. In addition, pulmonary function tests showed a significant improvement in forced expiratory volume and forced vital capacity after receiving probiotics. Discussion/Conclusion: Our findings demonstrate that 8-week treatment with probiotic supplementation can control T-helper 2-predominant and Th17 pro-inflammatory responses and improve forced vital and forced expiratory volume in asthmatic patients. It seems probiotics can be used besides common treatments for patients with asthma.


  • Open Access

    Explaining the Severity of Symptoms in Patients with Chronic Obstructive Pulmonary Disease based on Health-Promoting Style with a Mediating role of Personality Traits

    by Narges Khaton Akram, Nemat Sotodeh Asl, Raheb Ghorbani, Farhad Malek

    Aim and Background: Chronic obstructive pulmonary disease is one of the diseases that can limit the function of the lungs and consequently the function of the patient's whole body. Therefore, research related to this disease can be effective. Therefore, the aim of this study was to explain the severity of ...

  • Open Access

    The Relationship Between Sleep Quality and Quality of Life Among Patients With Asthma

    by Farhad Malek, Shokufe Khalil Sayah, Naim Sadat Kia, Elahe Ghods

    Asthma is a chronic recurring respiratory disease, and its prevalence is on the rise. A drop in the quality of life (QoL), as well as sleep problems, has been reported in asthmatic patients in the literature. This study was conducted to determine the relationship between QoL and sleep quality in asthmatic patients. This cross-sectional study recruited 76 diagnosed asthmatic outpatients from our university clinic. The subjects completed the self-administered 36-Item Short-Form Health Survey QoL questionnaire (SF-36) and the Pittsburgh Sleep Quality Index (PSQI) assessment. The study results revealed poor sleep quality in 55 (72.4%) of the subjects. The total sleep quality scores significantly and negatively correlated with the physical and mental components of QoL (moderate, p=0.00). All QoL subscales were significantly higher in patients with good sleep quality (PSQI: <5, p<0.00). Logistic regression analysis showed that good sleep quality (modified) could predict a mental component score (MCS) of more than 64. Poor sleep quality can bring down the scores of all QoL components in asthma patients and is the best predictor of their QoL. Therefore, sleep quality and QoL indicators could be applied as part of a better approach to classification, management, and control of asthma.


  • Open Access

    Comparison of prone and supine status on oxygenation of patients with COVID-19 with acute hypoxemia treated using reservoir mask; a randomized clinical trial

    by Mahboubeh Darban, Mohammad Memarian, Farhad Malek, Mohammad Bahrami, Ali Gohari

    Introduction: In early December of 2019, the first coronary pneumonia cases were identified, an emerging disease which is associated with higher mortality and morbidity and a higher proportion of deaths in population. Objectives: A significant number of patients progress towards acute respiratory distress syndrome (ARDS). Therefore, if we can control pulmonary involvement in the initial stages and before reaching severe degrees of ARDS, we will have given a great assistance to patients. Patients and Methods: A randomized clinical trial was conducted on 30 SARS-CoV-2 patients with acute respiratory hypoxia. The study population was randomly divided into two equal parts including group P (prone) and group S (supine). Patients in the prone group were placed in the prone position, six hours per day for three days, while received oxygen therapy by reserve bag and another group received oxygen therapy in the supine position by using reserve bag. Finally, the data were analyzed using statistical software. Results: In total, both groups showed significant results during three days of hospitalization, however, the considered variables of relative arterial oxygen pressure and PA/FiO2 during three days of the hospitalization in the prone group were significantly higher than the supine group (P=0.022 and P=0.012). Other variables did not show any statistically significant differences. Conclusion: Relative arterial oxygen pressure and PA/FiO2 in the prone group were significantly higher than the supine group. This finding shows the importance of prone status in the process of oxygenation and recovery of patients. Trial Registration: The trial was registered by the Iranian Registry of Clinical Trials (identifier: IRCT20151020024625N12; https://www.irct.ir/trial/55690/view, Ethical code# IR.SEMUMS.REC. 1399.201).

  • Open Access

    Comparison of the effects of doxycycline and povidone iodine in treatment of pleural effusion; an open label randomized clinical trial

    by Hamid Reza Hemmati, Armin Hadjizadeh, Farhad Malek, Raheb Ghorbani, Mehrdad Zahmatkesh, Setareh Soltani

    Introduction: Doxycycline is commonly used in treating pleural effusion. Povidone-iodine is another agent that has been used for treating pleural effusion. Objectives: We aimed to compare the effects of doxycycline and povidone iodine in treating pleural effusion. Patients and Methods: Forty-one patients with pleural effusion were enrolled and randomly divided into two groups. After insertion of the chest tube, pleurodesis was performed in the first group with povidone iodine and doxycycline in the second group. The chest tube clamped and opened one hour later. Then, connected to the suction through a double chest bottle. By decreasing of drainage to less than 50 cc per day, the chest tube was removed and the patients were evaluated three days later for pain, fever, empyema, recurrent effusion and long-term side effects at 7th, 30th, 60th and 90th day. Results: The pain intensity was not different between two groups (P > 0.05). None of the patients had empyema and other side effects including hemothorax or pneumothorax were not seen too. In a 90-day follow-up, 47.6% of doxycycline recipients and 25% of povidone iodine recipients experienced the recurrent effusion (P=0.133). Three patients had fever (one on the first day and two on the second day) in the doxycycline group, while fever was not observed in povidone iodine recipients. The cost of treatment in both groups was almost the same. Conclusion: Side effects of pleurodesis include pain, fever, recurrent effusion, cost in the two groups is almost equal, and both agents can be used as an effective drug for treating pleural effusion. Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT2015052918168N3; https://en.irct.ir/trial/16560, ethical code; IR.SEMUMS.REC.1394.91).


  • Open Access

    The combined effect of Algomed and a quadruple herbal brew of Iranian traditional medicine on the severity and outcome of COVID-19; a randomized controlled clinical trial recruiting inpatients

    by Rahimeh Eskandarian, Bahador Bagheri, Mehrdad Zahmatkesh, Farhad Malek, Mahboubeh Darban, Mohammad Memarian, Ali Gohari, Mohammad Amir Sarabi, Majid Mirmohammadkhani

    Introduction: Given the importance of coronavirus disease 2019 (COVID-19) as a worldwide issue and its health, psychological and social effects and some serious complications and consequences, it needs to find appropriate treatment for this emerging disease. Objectives: To evaluate the effectiveness of combination of Algomed and Mentha longifolia, Matricaria recutita, Althaea rosea and Malva sylvestris on the severity and outcomes of COVID-19. Patients and Methods: In a Randomized clinical trial we included 68 participants with confirmed COVID-19 through PCR tests and/or CT scan, who were admitted to non-ICU wards. The intervention group received four 300-mg Algomed tablets daily, and the quadruple herbal brew three times a day additionally while the control group received routine treatments. The brew was prepared using a large teabag containing 6 g of the four herbs (2 g of Mentha longifolia, 2 g of M. recutita, 1.4 g of Malva sylvestris and 0.6 g of A. rosea). The patients were compared daily from their admission to the end of the third day in terms of clinical and para-clinical symptoms, and outcomes. Results: The two groups were not significantly different in terms of age (P=0.657) and gender (P=0.798). The median and inter-quartile range of length of stay were respectively 3 and 2-4 days in the intervention group and 5 and 3-9 days in the controls, significantly higher in the control group (P<0.001). Comparing the two groups in terms of the difference between the third and the first day values showed a significant difference in white blood cells count, a reduction of 432.9 in the intervention group vs. an increase of 65.5 in the controls (P=0.049). Except for diarrhea, which happened more in the control group (P=0.020), the two groups were not significantly different in terms of other variations. Conclusion: The present study results indicated the effects of a combination of Algomed and the brew of M. longifolia, M. recutita, A. rosea and Malva sylvestris on reducing the length of stay. It is suggested that the findings of this research should be confirmed by more detailed study with bigger sample size. It is also recommended that same or similar research should be conducted in different geographic locations of the world to confirm the outcome of this research. The main limitation of this study is that it was performed only on hospitalized patients who had a milder form of the disease in terms of disease severity. Therefore, the benefits of the interventions cannot be generalized to all patients. Trial Registration: Registration of trial protocol has been approved by Iranian Registry of Clinical Trials (#IRCT20151228025732N51, https://en.irct.ir/trial/46828, ethical code#IR.SEMUMS.REC.1398.325).

    • 1 February 2021
      • Vol. 20  (2) , 116-125
    Open Access

    Prevalence of Sleep Apnea and its Associated Factors in Chronic Kidney Disease Patients.

    by Maliheh Moradzadeh, Majid Mirmohammadkhani, Mohammad Reza Tamadon, Kamyar Mansori, Farhad Malek

    This study aimed to determine the prevalence of sleep apnea and its associated factors in patients with chronic kidney disease (CKD). This population-based cross-sectional study included 47 CKD patients, referred to the dialysis unit of Kosar Hospital in Semnan, Iran, in 2017. Two questionnaires were used for data collection. The first questionnaire included demographic and clinical variables, and the second questionnaire (STOP-BANG questionnaire) was used to measure sleep apnea in CKD patients. Also, the Apnea-Hypopnea Index (AHI) was calculated for all patients and was considered as the gold standard. To determine the factors associated with sleep apnea, univariate and multiple logistic regression models were used. Finally, the area under the receiver operating characteristic curve (ROC) was determined for assessing the discriminative ability of the model, as well as the accuracy of STOP-BANG questionnaire. STATA version 14 was used for data analysis. The prevalence of sleep apnea in CKD patients was 53.2%. Also, its prevalence in women and men was 52% and 48%, respectively. In the multiple logistic regression model, body mass index (BMI) (OR: 1.21, 95% CI: 1.04-1.31) and blood urea nitrogen (BUN) (OR: 0.94, 95% CI: 0.91-0.98) had significant associations with sleep apnea in CKD patients; the area under the ROC curve was 0.7982 for this model. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the ROC curve of STOP-BANG questionnaire for AHI≥15 were 71.43, 61.54, 60, 72.73, and 0.6932, respectively. This study showed that the prevalence of sleep apnea in CKD patients was high. Given the acceptable validity of STOP-BANG questionnaire, this scale can be used to screen sleep apnea in CKD patients.


  • Open Access

    Assessment of Spirometric Parameters Changes Before and After of Protective Interventions among Workers of Chlorine Production Plant in Iran

    by Daryoush Pahlevan, Amir Shomali, Sara Pooryahya, Kamyar Mansori, Majid Mirmohammadkhani, Farhad Malek

    OBJECTIVES: This study was conducted to assess changes in spirometric parameters after protective interventions among workers at a chlorine production plant in Semnan, Iran during 2012-2016. METHODS: This quasi-experimental study included 100 workers at a chlorine production plant in Semnan during 2012-2016. Spirometric parameters (forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], FEV1/FVC, peak expiratory flow [PEF], and PEF occurring in the middle 50% of the patient's exhaled volume [PEF 25-75%]) were measured in all workers before the initial intervention in 2012. Protective interventions were then implemented for 4 consecutive years and the parameters were measured annually. A multivariable linear regression model was used to assess the factors affecting spirometric parameters before and after the protective interventions in SPSS version 24. RESULTS: The mean values of all spirometric parameters significantly increased after the protective interventions (p<0.05). Multivariable linear regression showed that age (beta=-0.40), body mass index (BMI) (beta=0.71; 95% confidence interval [CI], 0.11 to 1.31), and type of mask (beta=-7.88; 95% CI, -15.96 to -0.46) had significant effects on the mean difference in FVC. Similarly, age (beta=-0.35; 95% CI, -0.70 to -0.01), BMI (beta=0.80; 95% CI, 0.20 to 1.41) and type of mask (beta=-8.88; 95% CI, -16.98 to -0.79) had significant associations with the mean difference in FEV1. The type of mask (beta=-12.81; 95% CI, -25.01 to -0.60) had a significant effect on the mean difference in PEF. CONCLUSIONS: All spirometric parameters significantly increased in workers after protective interventions were implemented. Therefore, protective interventions to prevent respiratory disorders in workers exposed to chlorine gas are suggested.